Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001209191-21-007635

Chief Medical Officer sold 1,813 shares at $28.91 ($52,414)

From the SEC's structured data for this filing

Trades in this filing

Rosenberg Noah L. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-03 Sale : show line 1 in the form −1,250 $28.91 $36,138 44,657 D
2021-02-03 Sale : show line 2 in the form −563 $28.91 $16,276 44,094 D
Open-market sales · 1,813 sh · avg $28.91 · $52,414
Loading xslF345X03/doc4.xml…